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Research Article
SLEEP AND TREATMENT OUTCOME IN
POSTTRAUMATIC STRESS DISORDER: RESULTS FROM
AN EFFECTIVENESS STUDY
Miriam J. J. Lommen, Ph.D.,1,2∗ Nick Grey, DClinPsy.,3 David M. Clark, DPhil.,1,2,3
Jennifer Wild, DClinPsy.,1,2 Richard Stott, DClinPsy.,3 and Anke Ehlers, Ph.D.1,2,3
Background: Most patients with posttraumatic stress disorder (PTSD) suffer
from sleep problems. Concerns have been raised about possible detrimental ef-
fects of sleep problems on the efficacy of psychological treatments for PTSD. In this
study, we investigated the relation of session-to-session changes in PTSD symp-
toms and sleep, and tested whether sleep problems predicted poorer short- and
long-term treatment outcome. Methods: Self-reported sleep quality, sleep du-
ration, and PTSD symptoms were assessed weekly in a consecutive sample of 246
patients who received cognitive therapy for PTSD (CT-PTSD; Ehlers & Clark,
2000), and at follow-up (mean = 247 days posttreatment). Additionally, moder-
ating effects of medication use and comorbid depression were assessed. Results:
Sleep and PTSD symptoms improved in parallel. The relation was moderated by
depression: Sleep problems at the start of therapy did not predict improvement
in PTSD symptoms during treatment for patients without comorbid depression.
Patients with comorbid depression, however, showed less rapid decreases in PTSD
symptoms, but comparable overall outcome, if their sleep quality was poor. Resid-
ual sleep problems at the end of treatment did not predict PTSD symptoms at
follow-up once residual PTSD symptoms were taken into account. Conclusions:
CT-PTSD leads to simultaneous improvement in sleep and PTSD symptoms.
Sleep problems may reduce the speed of recovery in PTSD patients with comor-
bid depression. For these patients, additional treatment sessions are indicated to
achieve comparable outcomes, and additional interventions targeting sleep may
be beneficial. For those without comorbid depression, self-reported sleep prob-
lems did not interfere with response to trauma-focused psychological treatment.
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people will have problems sleeping. Among those who
develop posttraumatic stress disorder (PTSD), 70–91%
also have longstanding sleep disturbances, as evidenced
by increased self-reported sleep problems, and objec-
tive indicators of poorer sleep including less slow wave
sleep and increased stage 1 sleep and rapid eyemovement
density.[1] Sleep disturbances are seen as a core symptom
of PTSD,[2] and constitute one of the diagnostic crite-
ria for PTSD according to the Diagnostic and Statistical
Manual of Mental Disorders.[3, 4] An emerging view in the
literature, however, suggests that sleep disturbances may
not just be a symptom of PTSD, but a correlated inde-
pendent problem that may interfere with the efﬁcacy of
PTSD treatments and needs to be addressed directly in
treatment to maximize clinical outcomes.[5]
Some experts argue that insomnia is a mechanism in-
volved in the development andmaintenance of PTSD.[5]
This view is supported by longitudinal studies showing
that sleep problems before and shortly after trauma pre-
dict PTSD,[6–11] clinical studies showing that pretreat-
ment self-reported sleep disturbances predict lower re-
mittance rates in primary care patients with PTSD[12]
and that treatment of insomnia leads to improvement in
PTSD symptoms.[13,14]
The involvement of sleep in emotional and memory
processing[15] has raised concerns about detrimental
effects of sleep disturbances on cognitive behavioral
therapy (CBT) efﬁcacy.[16] Experimental studies indi-
cate that sleep promotes retention of fear extinction and
extinction generalization,[17–19] although not all studies
have found an effect of sleep on extinction memory.[20]
Most trauma-focused psychological PTSD treatments
include some elements of exposure to trauma memories
and trauma reminders. As extinction learning is seen
as a mechanism of exposure therapy,[21] an important
clinical question is whether sleep disturbances impair
therapeutic gains of trauma-focused psychological
PTSD treatments.
There is as yet insufﬁcient evidence on the relation
between sleep and PTSD, and the effects of sleep
problems on treatment effects in people with PTSD.
If sleep disturbance is a symptom of PTSD, sleep
would be expected to improve concurrently with other
PTSD symptoms during PTSD treatment. CBT for
PTSD has indeed a moderate effect on sleep distur-
bance according to a meta-analysis (ES = 0.404).[22]
Insomnia decreases in PTSD patients who show a
clinical signiﬁcant response to PTSD treatment,[23,24]
and improvements may be maintained for years after
treatment completion.[25] However, sleep disturbance,
in particular insomnia, does not seem to beneﬁt as much
as other PTSD symptoms from empirically supported
PTSD treatments,[5,26] and insomnia is the most
common residual symptom that typically remains in the
clinical range when PTSD is targeted in treatment.[23,24]
Moreover, there is a growing body of literature
showing that insomnia is predictive of other psy-
chiatric disorders including new-onset and recurrent
depression.[27–29] Comorbid depression is common in
PTSD (typically around 50%).[30] There is a large lit-
erature linking sleep problems and depression.[29] It is
thus of clinical importance that insomnia is effectively
targeted in the treatment of PTSD with and without
comorbid depression.
Previous studies on the relation between changes in
sleep and PTSD during therapy have been limited by fo-
cusing on pre- to posttreatment changes, consequently
prohibiting any analyses on the course of symptoms
across therapy. To investigate the nature of the relation
between sleep and PTSD more closely, this study ana-
lyzed session-to-session changes in sleep duration and
quality and PTSD symptoms in a consecutive sample of
patients who received cognitive therapy for PTSD (CT-
PTSD).[31] The aims of this study were to investigate
(1) the relation between changes in PTSD symptoms
and sleep across treatment, (2) whether sleep problems
at the beginning of treatment predicted poorer response
to treatment, and (3) whether residual sleep problems
at the end of treatment predicted poorer long-term
outcome, over and above what could be predicted from
PTSD symptoms at the end of treatment. Expanding
on research question 2, this study also explored the
effects of medication use and comorbid depression, as
both might affect sleep and PTSD pathology. Findings
with regard to the effect of these variables on treatment
outcome in patients with PTSD have been mixed, with
medication use as a moderator of treatment outcome
in some studies,[32] but not others,[33] and comorbid
depression as a moderator of treatment outcome in
some studies,[34,35] but only a nonspeciﬁc predictor in
others.[32,33] This study explored whether medication
use or a comorbid major depressive disorder at the start
of treatment moderated the effects of sleep problems on
PTSD symptom change. Investigation of these research
questions can inform therapists whether it is necessary
to speciﬁcally target sleep problems in patients with
PTSD.
METHOD
PARTICIPANTS AND PROCEDURE
The patients eligible for this study constitute a consecutive subsam-
ple (n = 246) of a cohort study of 330 patients aged 17–83 who received
psychological treatment for PTSD at aNationalHealth Service outpa-
tient clinic serving a deﬁned catchment area in South London between
April 2001 and August 2008. Weekly sleep measures were introduced
from September 2003 onwards. The local research ethics commit-
tee approved the study. Details can be found elsewhere.[33] Patients
met diagnostic criteria for PTSD according to the Structured Clinical
Interview for DSM-IV (SCID).[36] On average, the traumatic event
addressed in treatment happened 37.43 months before initial assess-
ment (range 2.50–360 months). At initial clinical interview, 91.9 % of
the patients reported sleep problems, with 72.2% reporting sleep on-
set problems, 91.9% mid sleep awakening, and 57.5% early morning
awakening. See Table 1 for demographic information.
Themajority of the patients included in this study (n=158, 64.23%)
also provided data at long-term follow-up, which on average took
place at 247 days after the last therapy session. Compared to pa-
tients who provided long-term follow-up data, those who did not re-
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TABLE 1. Demographic information (N = 246)
n (valid %)
Gender
Male 98 (40)
Marital status
Single 103 (43)
Married or cohabiting 90 (38)
Divorced or widowed 47 (20)
Educational degree
None 41 (17)
GCSE (school qualiﬁcation taken at age 16) or
equivalent professional education
99 (42)
A-level degree (school qualiﬁcation taken at age 18) 39 (17)
University level degree 56 (24)
Race
White 138 (56)
Black 63 (26)
Multiracial 44 (18)
Trauma type sought treatment for
Interpersonal trauma 141 (57)
Accidents 59 (24)
Event where another person was harmed or died 19 (8)
Another kind of traumatic experience 27 (11)
Comorbid Axis-I disorder 195 (79)
Comorbid anxiety disorder 107 (44)
Comorbid depression 129 (52)
Taking psychotropic medication (stable dose for at
least 2 months before treatment started)
102 (46)
ported more PTSD symptoms and poorer sleep quality and duration
at the end of the therapy, all Ps < .01, and were more likely to be di-
vorced or widowed, have a lower educational degree, have a race other
than white, and have been diagnosed with another Axis-I disorder, all
Ps < .05.
TREATMENT
Patients received a course of CT-PTSD[37]; a trauma-focused psy-
chological treatment that is based on Ehlers and Clark’s cognitive
model of PTSD.[31] It aims to change cognitive processes that main-
tain the perception of current threat in PTSD patients, by focus-
ing on the nature of the trauma memory, problematic appraisals,
and behavioral and cognitive strategies that maintain the appraisals
and problematic memory features. Details of treatment procedures
are found at http://oxcadat.psy.ox.ac.uk/downloads%20and%20links.
The treatment does not target sleep directly. Patients received on aver-
age 10.30, SD = 5.16, weekly therapy sessions, and optional monthly
booster sessions, M = 1.81, SD = 1.75. The analyses of session-to-
session changes in this study focus on the ﬁrst 10 therapy sessions to
ensure sufﬁcient valid data per data point.
MEASURES
Patients were interviewed by a trained clinician with the full
SCID at initial assessment and completed the following self-report
questionnaires to assess PTSD symptoms and sleep at initial assess-
ment and before each treatment session. This ensured that for each
patient, including dropouts, data at the last treatment session (includ-
ing any booster sessions) were available. Measures were also collected
at 6-month and 1-year follow-ups. Data from the last available follow-
up were used for the analysis (M = 247 days after the last session).
PTSD Symptoms (Excluding Sleep). PTSD symptom severity
was measured with the Posttraumatic Diagnostic Scale (PDS).[38] The
PDS is a 17-item self-report questionnaire assessing PTSD symptoms
as speciﬁed in the DSM-IV.[3] All items are rated on a 4-point scale
(0 = never to 3 = 5 times per week or more / almost always). To avoid
content overlap with the sleep measures, a revised sum score of 16
items, excluding the item “Difﬁculty falling or staying asleep,” was
used in the analyses (PDSwos).
SleepMeasures. Sleep quality was assessed by asking patients to
rate the quality of their sleep (Overall, how well did you sleep?) during the
past week on a scale between 0 (not at all well) and 100 (verywell). Sleep
duration was assessed by asking patients to report the mean number
of hours they slept per night in the past week (In the past week, how
much sleep did you have per night?). The sleep duration rating correlated
stronglywith the sleep duration according to clinical interview at initial
assessment, r = .83.
Depression. Current comorbid major depression was assessed
with the SCID,[36] referring to the last month.
DATA ANALYSIS
Parallel process latent growth modeling (LGM) was used (Mplus
version 7.11)[39] to analyze the session-to-session changes in PTSD
symptoms (excluding the sleep item; PDSwos) and sleep. Participants
who provided data on PTSD symptom severity and sleep for at least
three of 10 weekly sessions were included in the analyses, resulting in
a sample of 207 and 211 patients to assess the relation between sleep
quality and PTSD symptom severity, and the relation between sleep
duration and PTSD symptom severity, respectively. Missing (sum)
scores on PDSwos or sleep variables in the LGM analyses were esti-
mated using full information maximum likelihood. All analyses were
conducted both for the relation between PDSwos and sleep quality, and
the relation between PDSwos and sleep duration.
The parallel process LGM followed a bottom-up strategy, starting
with investigating variance (individual differences) between partici-
pants in PDSwos or sleep variables starting level (intercept), and vari-
ance in the change in PDSwos or the sleep variables across treatment
(slope). For more details on the speciﬁc models (see online Appendix
A). Model ﬁt was evaluated using ﬁt indices chi square, comparative ﬁt
index (CFI), and root-mean-square error of approximation (RMSEA).
Chi-square values were used to compare model ﬁt of different mod-
els. CFI values of >0.90 and RMSEA values of <0.08 were regarded
as adequate ﬁt.[40] Once the best model was selected, research ques-
tions 1 and 2 were investigated by testing the correlation between the
slope of the sleep variable and the slope of the PDSwos, and testing the
predictive effect of the intercept of the sleep variable on the slope of
the PDSwos, respectively. For the latter analysis, potential moderating
effects of medication and comorbid depression were also tested.
To investigate research question 3, regression analyses with the last
available sleep rating and PDSwos rating at the end of treatment were
included as independent variables predicting the PDSwos at the last
available long-term follow-up assessment.
RESULTS
DESCRIPTIVE STATISTICS
As shown inTable 2, PDSwos scores decreased by 50%
(mean change = 15.69) from initial assessment to the
end of treatment in the intent-to-treat sample, whereas
sleep quality ratings increased by a mean of 21.60 and
sleep duration improved by 52 min.
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Figure 1. Changes in PTSD symptoms (excluding sleep; PDSwos) and sleep quality over 10 treatment sessions (n = 207).
POSTTRAUMATIC SYMPTOMS AND SLEEP
QUALITY
See Figure 1 for a graphic display of changes in PTSD
symptoms and sleep quality over 10 treatment sessions.
As shown in Table 3, the random intercept/random
slope model showed best ﬁt (model 4a). The absence
of an improvement in model ﬁt by the addition of
the intercept–slope correlations within variables (model
4b) suggests that the level of PTSD symptoms at the
start of treatment did not correlate with the degree
of improvement in PTSD symptoms across treatment,
and the starting level of sleep quality did not correlate
with the degree of improvement in sleep quality. Since
the addition of a quadratic term to the random inter-
cept/random slope model (model 4a) for the PDSwos,
μ = 0.08, p < .001, improved model ﬁt, χ ² = 16.86,
TABLE 2. Descriptive statistics on PTSD symptoms and sleep variables at initial assessment, last session, and follow-up
(intent-to-treat)
Initial assessment Last session Follow-up
M SD n M SD n M SD n
PTSD symptoms without sleep item (PDSwos) 31.09 8.34 246 15.40 13.56 246 11.89 11.32 158
Sleep quality 33.70 21.16 231 55.30 25.28 233 55.78 29.27 148
Sleep duration (in hours) 5.14 1.70 240 6.01 1.84 238 6.16 1.62 153
TABLE 3. PTSD symptoms and sleep quality (n = 207)
PDSwos Sleep quality PDSwos Sleep quality
Model χ ² df CFI RMSEA μi σ i² μi σ i² μs σ s² μs σ s²
1. Fixed intercept 2,210.84 217 0.32 0.21 22.64 – 42.69 – – – – –
2a. Random intercept 1,175.82 215 0.67 0.15 22.59 97.02 42.99 305.47 – – – –
2b. 2a with intercept correlationa 1,083.87 214 0.70 0.14 22.58 97.20 42.92 306.42 – – – –
3. Random intercept, ﬁxed slope 491.26 212 0.91 0.08 29.02 103.68 37.96 312.85 −1.61 – 1.24 –
4a. Random intercept, random slope 359.79 210 0.95 0.06 29.05 87.09 37.92 273.09 −1.65 0.90 1.27 3.33
4b. 4a with intercept–slope correlation
within constructsb
359.35 208 0.95 0.06 29.05 86.23 37.94 283.35 −1.65 0.88 1.27 3.68
5a. 4a with quadratic term for PDS 342.93 209 0.96 0.06 29.87 87.44 37.91 273.12 −2.33 0.87 1.27 3.33
5b. 4a with quadratic term for sleep quality 357.26 209 0.95 0.06 29.05 87.09 36.79 273.44 −1.65 0.90 2.12 3.29
PDSwos = Posttraumatic Diagnostic Scale sum scores excluding sleep item.
aThe addition of the correlation between the intercepts of PDSwos and sleep quality, r = −0.69, P < .001, contributed signiﬁcantly to the model
ﬁt,χ ² = 91.95,df = 1, P < .001, and this correlation was therefore retained in models 3–5.
bThe addition of the correlation between the intercept and slope within PDSwos, r = 0.02, P = .80, and sleep quality, r = −0.07, P = .56, did not
signiﬁcantly contribute to the model ﬁt, and was therefore not retained in the next models.
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df = 1, P < .001 (model 5a), but not for sleep quality
(model 5b), model 5a was used to test research questions
1 and 2.
To assess the relation between change in sleep
problems and change in PTSD symptoms (question 1),
the correlation between the slope of sleep quality and
the slope of PDSwos was tested. Model ﬁt was good,
χ ² = 319.78, df = 208, CFI = 0.96, RMSEA = 0.05.
The correlation between the slopes was signiﬁcant,
r = −0.60, P < .001, and improved the model ﬁt,
χ ² = 5.90, df = 1, P = .02, showing that the
decrease in PDSwos correlated with the increase in sleep
quality with treatment.
To assess whether initial sleep problems predicted
poorer response to treatment (question 2), the effect of
the intercept of sleep quality on the slope of PDSwos
was added to the latter model. Model ﬁt was good, χ ²
= 318.06, df = 207, CFI = 0.96, RMSEA = 0.05. The
intercept of sleep quality did not predict the slope of
PDSwos, β = −0.13, P = .19 and did not improve the
model ﬁt signiﬁcantly, χ ² = 1.72, df = 1, P = .19.
Further analyses used cross-lagged path analysis to test
the temporal relationship between changes in sleep qual-
ity and changes in PTSD symptoms.The results indicate
simultaneous changes, and a bidirectional relationship
between sleep and PDSwos, as sleep problems predicted
changes in PTSDwos, and PTSDwos also predicted
changes in sleep problems (see online Appendix B).
POSTTRAUMATIC SYMPTOMS AND SLEEP
DURATION
The analyses including PTSD symptoms (PDSwos)
and sleep duration showed comparable results. Based on
the random intercept/random slope model (model 5a;
Table 4), the slope of sleep duration correlated signiﬁ-
cantly with the slope of PDSwos, r = −0.63, P < .001.
The intercept of sleep duration did not predict the slope
of PDSwos, β = −0.09, P = .35.
MODERATOR ANALYSIS
To test for possiblemoderation effects of psychotropic
medication, medication use and the interaction between
the intercept of sleep quality (or duration) and medica-
tion use were added together with the intercept of sleep
quality (or duration) as predictors of the slope of PDSwos.
In the sleep quality analysis, medication use signiﬁcantly
predicted the slope of PDSwos,P= .02; use ofmedication
was related to slower improvement in PDSwos during
treatment. The intercept of sleep quality and its inter-
action with medication use did not signiﬁcantly predict
the slope of PDSwos, P = .91, and P = .23, respectively.
In the sleep duration analysis, neither medication use,
the intercept of sleep duration, nor the interaction term
predicted the slope of PDSwos, P = .13, P = .92, and
P = .37, respectively.
Comorbid depression signiﬁcantly moderated the
effect of the intercept of sleep quality on the slope of
PDSwos: comorbid depression and the interaction term
signiﬁcantly predicted the slope of PDSwos, P = .001,
and P = .01, respectively, but the intercept of sleep
quality did not, P = .61. A multigroup model explored
this interaction effect. The intercept of sleep quality did
not predict the slope of PDSwos in patients without co-
morbid depression, β = 0.08, P = .61, but did predict the
slope of PDSwos in patients with comorbid depression,
β = −0.45, P = .001.However, there was nomoderating
effect of comorbid depression in the analysis of sleep
duration: comorbid depression, the intercept of sleep du-
ration, and the interaction term did not predict the slope
of PDSwos, P = .55, P = .52, and P = .97, respectively.
In sum, both sleep measures (sleep quality and dura-
tion) increased across treatment, whereas PTSD symp-
toms (PDSwos) decreased. The increase in both sleep
measures correlated highly with the decrease in PDSwos.
The intercepts of the sleep measures did not predict the
slope of the PDSwos, with the exception that the inter-
cept of sleep quality, but not sleep duration, predicted
a slower decrease in PDSwos for patients with comorbid
depression. A regression analysis further tested whether
this also applied to ﬁnal treatment outcome: PDSwos at
the start of treatment, β = 0.47, P < .001, and comorbid
depression, β = 0.28, P < .001, signiﬁcantly predicted
PDSwos at the last session, but not sleep quality or its
interaction with depression.
LONG-TERM TREATMENT OUTCOME
For the subsample of patients who provided data on
the long-term follow-up (n = 158), the average PDSwos
score was 11.35, SD = 10.90, at the end of treatment
and 11.89, SD = 11.32, at follow-up, indicating stable
treatment effects. Sleep quality, M = 59.40, SD = 24.62;
M = 55.87, SD = 29.27, and sleep duration, M = 6.25,
SD = 1.89; M = 6.16, SD = 1.62, remained similar from
end of treatment to follow-up, respectively.
Regression analyses showed that sleep quality pre-
dicted PDSwos at follow-up when considered as the sole
predictor, β = −0.46, P < .001, R2 = 21.3%, but was no
longer a signiﬁcant predictor, β = −0.08, P = .16, after
inclusion of PDSwos at the end of treatment, β = 0.74,
P< .001,R2 =61.8%.Similarly, sleepduration at the end
of treatment predicted PDSwos at follow-up, β = −0.40,
P < .001, R2 = 16.3%; but was not longer a signiﬁcant
predictor β = −0.09, P = .10, when PDSwos at end of
treatment was included, β = 0.75, P < .001;R2 = 62.6%.
DISCUSSION
The aim of this study was to investigate the relation
between changes in PTSD symptom severity and
sleep problems in a clinical sample of PTSD patients
receiving trauma-focused cognitive therapy for PTSD
that did not directly target sleep. Session-to-session
decreases in PTSD symptoms correlated highly with
session-to-session increases in sleep quality and du-
ration. Interestingly, sleep quality and sleep duration
at the start of treatment did not predict the decrease
Depression and Anxiety
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TABLE 4. PTSD symptoms and sleep duration (n = 211)
PDSwos Sleep
duration
PDSwos Sleep
duration
Model χ ² df CFI RMSEA μi σ i² μi σ i² μs σ s² μs σ s²
1. Fixed intercept 2,609.97 217 0.33 0.23 22.40 – 5.51 – – – – –
2a. Random intercept 1,215.39 215 0.72 0.15 22.27 96.06 5.50 1.95 – – – –
2b. 2a with intercept correlationa 1,161.66 214 0.74 0.15 22.27 96.21 5.50 1.96 – – – –
3. Random intercept, ﬁxed slope 563.48 212 0.90 0.09 28.75 103.16 5.28 1.96 −1.61 – 0.06 –
4a. Random intercept, random
slope
455.70 210 0.93 0.07 28.80 87.52 5.28 1.90 −1.67 0.90 0.06 0.01
4b. 4a with intercept–slope
correlation within constructsb
455.15 208 0.93 0.08 28.81 85.21 5.28 1.90 −1.67 0.87 0.06 0.01
5a. 4a with quadratic term for PDS 437.51 209 0.94 0.07 29.65 87.88 5.28 1.90 −2.36 0.86 0.06 0.01
5b. 4a with quadratic term for sleep
quality
453.42 209 0.93 0.07 28.80 87.51 5.22 1.90 −1.67 0.90 0.10 0.01
PDSwos = Posttraumatic Diagnostic Scale sum scores excluding sleep item.
aThe addition of the correlation between the intercepts of PDSwos and sleep duration contributed signiﬁcantly to the model ﬁt, and this correlation
was therefore retained in models 3–5.
bThe addition of the correlation between the intercept and slope within PDSwos and sleep duration, respectively, did not signiﬁcantly contribute
to the model ﬁt, and was therefore not retained in the next models.
in PTSD symptom severity across treatment. Thus,
the level of sleep problems at the start of treatment
was not related to poorer treatment outcome in the
whole sample. However, additional analyses showed a
moderating effect of comorbid depression: sleep quality
at the start of treatment predicted slower change in
PTSD symptoms per treatment session, but not poorer
overall outcome, for patients with comorbid depression,
but not for those without depression. This moderating
effect of comorbid depression was not found in the
analyses including sleep duration. Both self-reported
sleep quality and sleep duration at the end of treatment
predicted PTSD symptom severity at follow-up, on av-
erage 247 days later, but was no longer predictive when
PTSD symptom severity at the end of treatment was
taken into account, suggesting that sleep did not predict
unique variance in long-term treatment outcome.
Overall, the ﬁndings do not support the hypothesis
of detrimental effects of the presence of sleep problems
on the efﬁcacy of cognitive behavioral treatments for
PTSD,[16] with the exception that for patients with co-
morbid depression poor sleep quality at the start of treat-
ment predicted a slower decrease in PTSD symptoms
over the ﬁrst 10 sessions, but not ﬁnal treatment out-
come. Possibly sleep problems associated with depres-
sion are more severe or differ qualitatively from those
associated with anxiety problems alone,[41,42] with only
the former interfering with rapid gains in therapy. It is
unclear whether this is due to biological, psychological,
or social factors. Comorbid depression in patients with
PTSD has been related to social problems like unsta-
ble housing conditions,[33] which could interfere with
sleep directly and could make the treatment less trauma
focused, resulting in a slower treatment response.More-
over, patientswith comorbiddepressionmight have been
less motivated or might have had less energy to do as-
signments outside of the sessions, resulting in a slower
recovery. However, the moderating effect of comorbid
depression was not replicated in the analyses on the ef-
fect of sleep duration on PTSD symptoms, and should
therefore be interpreted with caution. Other sleep fac-
tors that have been strongly related to insomnia, such as
sleep latency, wake time after sleep onset, sleep main-
tenance difﬁculties, and perceived sleep-related daytime
symptoms, might have had a stronger inﬂuence on sleep
quality than on sleep duration ratings. This may help to
explain the discrepancy in ﬁndings between these two
sleep variables.
On average, CT-PTSD led to an increase of nearly
1 hr in self-reported sleep duration (see Table 2). This
is a substantial improvement, given that CBT for in-
somnia leads to an average improvement of 30–60 min
in sleep duration.[43] The improvement in sleep dura-
tion observed with CT-PTSD is also well within the
range of sleep gains observed when sleep is directly tar-
geted in PTSD. A study of combat veterans with PTSD
found an increase of 30 min with four sessions of CBT
for insomnia and imagery rehearsal therapy for night-
mares (from 4.70 to 5.20 hr of sleep).[14] Although sev-
eral studies have found that sleep problems remained in
the clinical range in treatment responders who received
PTSD treatment,[23,25] the average sleep duration at the
end of treatment in the intent-to-treat sample (6.01 hr)
lies within one standard deviation of the national repre-
sentative sample (M = 7.04, SD = 1.55),[44] suggesting
that reduced sleep duration increased to a nonclinical
level.
But how does PTSD treatment affect sleep? One pos-
sibility may lie in the arousal associated with PTSD.[1]
A study on CBT for insomnia found that reduced
arousal and hypervigilance related to better treatment
outcomes.[45] Since CT-PTSD leads to improvements
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of arousal and hypervigilance, it may directly improve
sleep too. Likewise, reducing re-experiencing symptoms
includingnightmaresmay result in lesswakening and less
avoidance of sleep. For some patients sensory cues asso-
ciated with going to bed (e.g., darkness, lying down) are
powerful triggers of re-experiencing symptoms, which
they learn to discriminate from the traumatic situation
in therapy. Furthermore, patients learn to drop coping
strategies that interfere with sleep such as worry and ru-
mination. Finally, even though sleep problems were not
directly targeted in treatment, some of the procedures
may have had some overlap with advice on sleep hy-
giene, for example, some patients worked on reducing
avoidance of going to bed for fear of nightmares or in-
truders. It is also conceivable that the weekly self-ratings
about sleep quality and duration might have had a small
therapeutic effect itself, but as these were not discussed
with the therapist, it is unlikely that this would account
for the large change observed in this study.
A few limitations should be taken into account. First,
simple self-report scales were used to measure the aver-
age sleep quality and duration over a week, and objective
measures of sleep that may be able to detect more subtle
relations between sleep and PTSD symptoms were not
included. However, although sleep duration is underes-
timated in self-report measures compared to objective
sleep measures, these are correlated in a way that those
with the shortest sleep duration according to objective
measures also self-report the shortest sleep duration.[46]
Furthermore, the measures showed convergent validity
since similar results were obtained for both sleep quality
and sleep duration. Second, because this study included
a patient sample, it is unclear if sleep problems were
already present before the trauma and may have con-
tributed to PTSD vulnerability, or whether sleep prob-
lems developed as a response to the trauma. Investigat-
ing whether there are common risk factors underlying
PTSD and sleep disturbances might be an interesting
future direction. Third, the sleep problems might not
have been severe or long-lasting enough to interfere
with PTSD treatment. This seems unlikely, since the
study investigated a clinical sample of PTSD patients
withmoderate to severe chronic PTSDwho experienced
the traumatic event on average 3 years before the start
of treatment and had not recovered since. Fourth, it is
unclear whether the results can be generalized to other
types of treatment for PTSD that rely more heavily on
exposure. Fifth, follow-up analyses were restricted to the
64% of the patient sample that reported follow-up data.
Because this group reported less PTSDand sleep pathol-
ogy at the end of treatment than those patients who did
not provide follow-up data, it is unclear if the results gen-
eralize to patients with higher levels of symptomatology
at the end of treatment.
The strengths of this study include use of a rep-
resentative sample of consecutively referrals, and the
combination of the longitudinal design of assessing
sleep and PTSD symptoms at each treatment session
with the statistical method to analyze the data, which
allowed studying the course of the symptomatology as
well as a sophisticated way of dealing with missing data.
Furthermore, the data collection method made sure
that outcome scores at the last treatment session were
available for every patient, including dropouts.
This study provides a clear answer to the clini-
cally relevant question of whether clinicians should
be hesitant to start trauma-focused psychological ther-
apy for PTSD if the patient reports signiﬁcant
sleep problems: overall, self-reported levels of sleep
problems at the start of treatment did not pre-
dict treatment effectiveness. However, in those with
comorbid depression, lower self-reported sleep quality
predicted slower improvement in PTSD symptoms. It
therefore appears advisable to assess depression and sleep
disturbances in patients with PTSD. Although these
symptoms appear to be part of the PTSD syndrome
and improve in parallel with PTSD symptoms during
trauma-focused treatment, patients with comorbid de-
pression and sleep problems required more treatment
sessions to achieve comparable outcomes. It remains to
be tested whether they might further beneﬁt from ad-
ditional interventions targeting sleep or depression that
could be added to the trauma-focused treatment. It also
remains to be tested whether treating remaining sleep
problems with either speciﬁc psychological sleep inter-
ventions, or medication that have shown to be effective
in reducing sleep complaints in PTSD (e.g., olanzapine,
prazosin)[47–49] could further improve sleep. In conclu-
sion, most people with PTSD report sleep problems and
only for those with comorbid depression poorer self-
reported sleep quality, not sleep duration, was related to
slower recovery, but not treatment outcome at the end
of treatment. For those without comorbid depression,
self-reported sleep problems do not affect the degree
to which they beneﬁt in the short or long term from
trauma-focused cognitive therapy for PTSD.
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APPENDIX A
To investigate variance in the intercept (starting level)
and slope (change across treatment) of PDSwos and the
sleep variable, the goodness of ﬁt for the following mod-
els was computed (see Tables 1 and 2).
1. A null model (ﬁxed intercepts), which equates to the
null hypothesis of no change over time or variation
between subjects for both the PDSwos and sleep vari-
able.
2. A random intercept model, in which variation of the
interceptswas allowed (2a).The addition of the corre-
lation between the intercepts of the PDSwos and sleep
variable was also evaluated (2b).
3. A random intercept, ﬁxed slope model, which as-
sumed a similar change over time for all subjects.
4. A random intercept/random slope model, in which
variation between subjects in intercept and slope was
allowed (4a). The addition of the correlation between
the intercept and slope of the PDSwos and the corre-
lation between the intercept and slope of sleep was
also evaluated (4b).
5. Additionally, we tested whether adding a quadratic
term to the growth curve estimation for the PDSwos
(5a) or for the sleep variable (5b) increased model ﬁt.
APPENDIX B
CROSS-LAGGED RELATIONSHIP PTSD
SYMPTOMS AND SLEEP
A cross-lagged panel analysis was run including au-
toregressive paths, correlation between the sleep variable
and PTSD symptoms (PDSwos) at each time point, and
cross-lagged paths that were set to be equal over time.
The ﬁt of the model testing the temporal relationship
between sleep quality and PDSwos was at the boundary
of adequate model ﬁt, χ ² = 424.00, df = 160, CFI =
0.91, RMSEA = 0.09. Cross-lagged paths were all sig-
niﬁcant, with PDSwos as a highly signiﬁcant predictor of
sleep quality,B= −0.38,P< .001, as well as sleep quality
signiﬁcantly predicting of PTSD symptoms, B = −0.02,
P = .01. Omitting the cross-lagged paths with PDSwos
as a predictor of sleep quality led to decreased model ﬁt,
χ ² = 61.34, df = 1, P < .001. Omitting the cross-
lagged paths with sleep quality as a predictor of PDSwos
also led to decreasedmodel ﬁt,χ ² = 6.68,df = 1, P =
.01. Sleep quality predicted 2–4% of variance in PDSwos
across weekly sessions, and PDSwos predicted 1–6% of
the variance in sleep quality, both over and beyond the
variation explained by autoregressive paths and the cor-
relation between sleep quality and PDSwos. These results
indicate a bidirectional relationship betweenPDSwos and
sleep quality.
The cross-lagged path analysis including sleep dura-
tion and PDS showed a similar pattern of results, but did
not reach adequate model ﬁt.
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